Vivimed Labs to acquire Hungary-based Soneas
New Delhi: Drug firm Vivimed Labs said it has inked pacts to acquire Hungary-based contract development and manufacturing firm Soneas for an undisclosed amount.
Vivimed Labs Spain S.L, the parent of Uquifa S.A has signed definitive agreements to facilitate the acquisition of Soneas, Vivimed Labs said in a BSE filing.
"The acquisition broadens Uquifas market offering in the contract development and manufacturing organization (CDMO) space by enhancing its ability to now undertake preclinical, phase I, II and III NCE project development," Vivimed Labs said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd